We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$984M
Cap. Flow %
18.18%
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$64.8M
2
JD icon
JD.com
JD
+$44.9M
3
MELI icon
Mercado Libre
MELI
+$40.5M
4
NTES icon
NetEase
NTES
+$38M
5
BEKE icon
KE Holdings
BEKE
+$21.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.21%
2 Technology 22.71%
3 Communication Services 13.35%
4 Financials 4.97%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBOE icon
926
Cboe Global Markets
CBOE
$29.9B
$26K ﹤0.01%
269
+40
+17% +$3.91K
IRM icon
927
Iron Mountain
IRM
$36.1B
$26K ﹤0.01%
721
+117
+19% +$3.91K
AVLR
928
DELISTED
Avalara, Inc.
AVLR
$26K ﹤0.01%
202
+32
+19% +$4.93K
CMA
929
DELISTED
Comerica
CMA
$25K ﹤0.01%
350
+60
+21% +$3.93K
MRSN
930
DELISTED
Mersana Therapeutics
MRSN
$25K ﹤0.01%
63
PTGX icon
931
Protagonist Therapeutics
PTGX
$9.44B
$25K ﹤0.01%
970
+90
+10% +$2.28K
RPTX
932
DELISTED
Repare Therapeutics
RPTX
$25K ﹤0.01%
830
-15
-2% -$510
WRB icon
933
W.R. Berkley
WRB
$26.6B
$25K ﹤0.01%
754
+108
+17% +$3.33K
WU icon
934
Western Union
WU
$2.21B
$25K ﹤0.01%
1,025
+160
+18% +$3.77K
CNST
935
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$25K ﹤0.01%
1,085
-5
-0.5% -$151
C icon
936
Citigroup
C
$226B
$24K ﹤0.01%
333
+222
+200% +$14.8K
CHRS icon
937
Coherus Oncology
CHRS
$196M
$24K ﹤0.01%
1,655
EG icon
938
Everest Group
EG
$14.4B
$24K ﹤0.01%
100
+16
+19% +$3.81K
HSIC icon
939
Henry Schein
HSIC
$9.82B
$24K ﹤0.01%
355
+56
+19% +$3.79K
NDSN icon
940
Nordson
NDSN
$17.3B
$24K ﹤0.01%
125
+16
+15% +$3.12K
NKTX icon
941
Nkarta
NKTX
$172M
$24K ﹤0.01%
740
-10
-1% -$478
OMER icon
942
Omeros
OMER
$959M
$24K ﹤0.01%
1,390
-25
-2% -$486
PSNL icon
943
Personalis
PSNL
$1.51B
$24K ﹤0.01%
990
+95
+11% +$3.26K
QNCX icon
944
Quince Therapeutics
QNCX
$29.5M
$24K ﹤0.01%
3
UHS icon
945
Universal Health Services
UHS
$10.5B
$24K ﹤0.01%
182
+24
+15% +$3.18K
ZGNX
946
DELISTED
Zogenix, Inc.
ZGNX
$24K ﹤0.01%
1,255
-20
-2% -$410
ANNX icon
947
Annexon
ANNX
$886M
$23K ﹤0.01%
860
-25
-3% -$688
ARCT icon
948
Arcturus Therapeutics
ARCT
$211M
$23K ﹤0.01%
580
+20
+4% +$1.19K
LAD icon
949
Lithia Motors
LAD
$8.26B
$23K ﹤0.01%
61
+8
+15% +$2.87K
REG icon
950
Regency Centers
REG
$14.1B
$23K ﹤0.01%
419
+64
+18% +$3.33K

Similar funds

Penserra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.

  • Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
  • Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
  • Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
  • Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
  • Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.

Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.